Keeping You Informed

A new American Cancer Society (ACS) report finds that the incidence of breast cancer in women has continued to increase, rising by 1% a year during 2012 to 2021, for all women combined.

Millions of Americans with cancer likely struggle to access some of the most advanced, state-of-the-art treatments being tested in clinical trials for their disease, according to a new analysis from the American Society of Clinical Oncology (ASCO).

Despite a twofold increase in colorectal cancer screening among average-risk individuals aged 45 to 49 years after the 2021 recommendation, disparities in socioeconomic status and locality underscore the need for targeted interventions.

On September 20, 2024, the Federal Trade Commission sued the three largest pharmaceutical benefit managers (PBMs) – Caremark Rx, Express Scripts (ESI), and Optum Rx – alleging competition and consumer protection law violations.

In 2023, COA’s Patient Advocacy Network (CPAN) provided advocacy, education, and engagement opportunities in multiple ways.

While the new year is always filled with energy and enthusiasm, it is also important to reflect on the impact of our advocacy accomplishments in 2022.

The word support embodied 2021 for CPAN. Represents The Patient Voice at the COA Conference, Supported our National Initiatives, Kept Chapters Active During COVID, New Practice Members, Advocacy Summit, Monthly News Bulletins and Shined the Light on 11 Different Cancer Centers, Nationally Recognized Speakers and Advocacy/Oncology Education to our Audience, Customized Educational Resources, Supported Our Corporate Members Advocacy Initiatives and more.

Upcoming Advocacy Chats: Educational Conversations on Cancer Advocacy and Policy […]

Upcoming Advocacy Chats – Educational Conversations on Cancer Advocacy and Policy […]

Upcoming Advocacy Chats – Educational Conversations on Cancer Advocacy and Policy […]